| Tina Marie Bauman, RN, MSN, APN, AGN-BC | |
|
450 W Highway 22, Barrington, IL 60010-1919 | |
| (847) 842-4803 | |
| Not Available |
| Full Name | Tina Marie Bauman |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist |
| Location | 450 W Highway 22, Barrington, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407349343 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364S00000X | Clinical Nurse Specialist | 209.015539 (Illinois) | Primary |
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700824455 PECOS PAC ID: 7810800935 Enrollment ID: O20031106000064 |
News Archive
Almost half of U.S. youth who experience violence, abuse or crime have had at least one of their victimizations known to school, police or medical authorities, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The BioDigital Human is an interactive, virtual model of the human body that addresses huge deficiencies in health education and communication. From diagnosis to drugs to devices, the human provides an engaging way to really understand complex health information.
Dakim, Inc. announced today that it is expanding distribution of its dementia-fighting Dakim® BrainFitness(TM) System to Canada through a partnership with Tock Tick, Inc. Dakim's touch screen-based system is the #1 cognitive stimulation product in U.S. senior living communities, providing an entertaining and easy-to-use brain workout that is specifically designed to help seniors maintain their brain health.
Stigma and discrimination, such as homophobia and racism, impede engagement in HIV prevention and use of biomedical tools for treatment in both HIV-negative and HIV-positive gay and bisexual men, according to a Rutgers study.
Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in patients aged 3 to 16 with neurologic conditions associated with problem drooling, such as cerebral palsy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tina Marie Bauman, RN, MSN, APN, AGN-BC 29373 Network Pl, Chicago, IL 60673-5038 Ph: (847) 390-5900 | Tina Marie Bauman, RN, MSN, APN, AGN-BC 450 W Highway 22, Barrington, IL 60010-1919 Ph: (847) 842-4803 |
News Archive
Almost half of U.S. youth who experience violence, abuse or crime have had at least one of their victimizations known to school, police or medical authorities, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.
The BioDigital Human is an interactive, virtual model of the human body that addresses huge deficiencies in health education and communication. From diagnosis to drugs to devices, the human provides an engaging way to really understand complex health information.
Dakim, Inc. announced today that it is expanding distribution of its dementia-fighting Dakim® BrainFitness(TM) System to Canada through a partnership with Tock Tick, Inc. Dakim's touch screen-based system is the #1 cognitive stimulation product in U.S. senior living communities, providing an entertaining and easy-to-use brain workout that is specifically designed to help seniors maintain their brain health.
Stigma and discrimination, such as homophobia and racism, impede engagement in HIV prevention and use of biomedical tools for treatment in both HIV-negative and HIV-positive gay and bisexual men, according to a Rutgers study.
Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in patients aged 3 to 16 with neurologic conditions associated with problem drooling, such as cerebral palsy.
› Verified 4 days ago
Hanneli M Fanega, APN, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 405 Lake Zurich Rd, Barrington, IL 60010 Phone: 847-381-5599 Fax: 847-381-1431 |